Reduced levels of lysyl oxidase in plasma extracellular vesicles: a potential biomarker associated with the risk of brain metastases in lung adenocarcinoma - Takeaways - MDSpire

Reduced levels of lysyl oxidase in plasma extracellular vesicles: a potential biomarker associated with the risk of brain metastases in lung adenocarcinoma

  • By

  • Jing Li

  • Yu Pei

  • Jia-Li Sun

  • Fen Hu

  • Han-Xue Yang

  • Jun Zhou

  • Cong-Ting Wu

  • Xingjie Hao

  • Wei Gong

  • Yang Yao

  • Yi Liu

  • March 12, 2026

  • 0 min

Share

  • 1

    Lung adenocarcinoma has a high propensity for brain metastasis, affecting 30-50% of patients and leading to poor survival rates.

  • 2

    Current imaging techniques for detecting brain metastases are costly and may not accurately differentiate between true progression and other conditions.

  • 3

    Extracellular vesicles (EVs) are promising non-invasive biomarkers for early identification of brain metastases in lung adenocarcinoma.

  • 4

    The study analyzed plasma EVs from 260 patients with stage IV lung adenocarcinoma to identify proteins associated with brain metastases.

  • 5

    This research aims to establish a liquid biopsy tool for monitoring high-risk lung adenocarcinoma patients and developing targeted therapies.

Original Source(s)

Reduced levels of lysyl oxidase in plasma extracellular vesicles: a potential biomarker associated with the risk of brain metastases in lung adenocarcinoma

  • by Jing Li, Yu Pei, Jia-Li Sun, Fen Hu, Han-Xue Yang, Jun Zhou, Cong-Ting Wu, Xingjie Hao, Wei Gong, Yang Yao, Yi Liu

  • March 12, 2026

Related Content

An ASCO preview: What to watch for at cancer research’s big meeting

Efficacy of IoT-based perioperative respiratory rehabilitation for lung resection: Protocol of a randomized controlled trial

Gene amplification in the premalignant stages of non-small cell lung cancer development